Matches 1 - 50 out of 52 1 2 >


Match Document Document Title
US20090017065 Vectors and cells for preparing immunoprotective compositions derived from transgenic plants  
The inventions is drawn towards vectors and methods useful for preparing genetically transformed plant cells that express immunogens from pathogenic organisms which are used to produce...
US20120034265 INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS  
Polypeptides, polynucleotides, methods, compositions, and vaccines comprising influenza hemagglutinin and neuraminidase variants are provided.
US20120034264 INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS  
Polypeptides, polynucleotides, methods, compositions, and vaccines comprising (avian pandemic) influenza hemagglutinin and neuraminidase variants are provided.
US20090175908 Influenza Hemagglutinin And Neuraminidase Variants  
Polypeptides, polynucleotides, methods, compositions, and vaccines comprising influenza hemagglutinin and neuraminidase variants are provided.
US20090017052 Methods of determining lethality of pathogens and malignancies involving replikin peak genes  
The present invention provides methods of identifying lethal, virulent and rapidly replicating viruses, organisms, and malignancies comprising comparing Replikin concentrations among different...
US20080069821 Influenza Hemagglutinin And Neuraminidase Variants  
Polypeptides, polynucleotides, methods, compositions, and vaccines comprising (avian pandemic) influenza hemagglutinin and neuraminidase variants are provided.
US20100158942 ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS  
The present invention relates, in general, to attenuated negative-strand RNA viruses having an impaired ability to antagonize the cellular interferon (IFN) response, and the use of such attenuated...
US20090155309 Novel vaccine  
The invention relates to the use of a non-live influenza virus antigen preparation, particularly a split influenza virus preparation, in the manufacture of a vaccine formulation for a one-dose...
US20090092579 NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID  
Disclosed are novel methods for combating diseases characterized by deposition of amyloid. The methods generally rely on immunization against amyloidogenic proteins (proteins contributing to...
US20080311154 COLD-ADAPTED EQUINE INFLUENZA VIRUSES  
The present invention provides experimentally-generated cold-adapted equine influenza viruses, and reassortant influenza A viruses comprising at least one genome segment of such an equine...
US20080260781 PROTEOSOME INFLUENZA VACCINE  
Improved forms of vaccines which comprise proteosomes and protein antigens are described. Vaccines which contain influenza HA as the antigen are used for illustration as to demonstrate efficacy....
US20100136050 Extracellular Matrix Materials as Vaccine Adjuvants for Diseases Associated with Infectious Pathogens or Toxins  
Disclosed are vaccines and vaccine adjuvants useful in the treatment and/or prevention of infection and diseases associated with infectious pathogens, such as tetanus, as well as diseases...
US20090252762 NOVEL PROTEOSOME-LIPOSACCHARIDE VACCINE ADJUVANT  
An adjuvant complex composed of bacterial outer membrane protein proteosomes complexed to bacterial liposaccharide is prepared to contain the component parts under a variety of conditions. The...
US20090162398 Methods and Compositions for Immunizing Pigs Against Porcine Circovirus  
The present invention relates to the isolation and identification of two new strains of type 2B porcine circovirus. These two new strains of porcine circovirus may be used for the preparation of...
US20100129399 LINEAR EXPRESSION CONSTRUCTS FOR PRODUCTION OF INFLUENZA VIRUS PARTICLES  
The present invention provides a linear expression construct free of any conventional amplification and/or selection sequences comprising an RNA polymerase I (polI) promoter and a polI termination...
US20110070263 INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS  
Polypeptides, polynucleotides, methods, compositions, and vaccines comprising influenza hemagglutinin and neuraminidase variants are provided.
US20080299151 Influenza vaccines  
Described herein are vaccines and the use of naked DNA and/or RNA encoding hemagglutinin (HA) from pandemic influenza, e.g., the 1918 H1N1 and/or the 1957 H2N2 and/or the 1968 H3N2 influenza A...
US20080026007 Potentiation of the immune response  
A method for stimulating proliferation of T-cells containing cytoplasmic post-prolyl dipeptidase activity; the method, in one aspect, involves contacting the T-cells with an organic compound at a...
US20100136052 REPLICATION DEFICIENT INFLUENZA VIRUS FOR THE EXPRESSION OF HETEROLOGOUS SEQUENCES  
The present invention covers a novel replication deficient influenza virus comprising a modified NS1 segment coding for a NS1 protein lacking a functional RNA binding domain and functional...
US20140220075 MULTI PLASMID SYSTEM FOR THE PRODUCTION OF INFLUENZA VIRUS  
Vectors and methods for the production of influenza viruses suitable as recombinant influenza vaccines in cell culture are provided. Bi-directional expression vectors for use in a multi-plasmid...
US20100183667 Vaccine Comprising an Oil in Water Emulsion Adjuvant  
The present invention provides an immunogenic composition comprising an antigen or antigen composition and an adjuvant composition comprising an oil in water emulsion, wherein said oil in water...
US20090081253 COMPOSITION  
The present invention relates to influenza vaccine formulations and vaccination regimes for immunising against various diseases. In particular the invention relates to vaccine formulations...
US20080181911 Use Of An Influenza Virus, An Oil-In-Water Emulsion Adjuvant, To Induce Cd4 T-Cell And/Or Improved B-Memory Cell Response  
The present invention relates to influenza vaccine formulations and vaccination regimes for immunising against influenza disease. In particular the invention relates to vaccine formulations...
US20090280142 METHODS OF DIAGNOSIS AND TREATMENT OF OSTEOPOROSIS  
A method of detecting osteoporosis in a mammalian is disclosed herein which includes: a) obtaining a sample of a bone related tissue or cells; andb) measuring the concentration of at least a...
US20130189303 RECOMBINANT SWINE INFLUENZA VIRUS AND USES THEREOF  
Recombinant, chimeric porcine influenza viruses are disclosed that include hemagglutinin segments from more than one influenza virus subtype. Also described are methods of producing the...
US20100221349 NUCLEIC ACID CONSTRUCTS  
A nucleic acid construct comprising a chimeric promoter sequence and a cloning site for insertion of a coding sequence in operable linkage with the chimeric promoter, wherein the chimeric promoter...
US20080254066 Nanoemulsion Vaccines  
The present invention provides methods and compositions for the stimulation of immune responses. Specifically, the present invention provides methods and compositions for the use of nanoemulsion...
US20090324639 COMPOSITIONS AND METHODS FOR ACTIVATING INNATE AND ALLERGIC IMMUNITY  
Methods for making and using therapeutic formulations of Proteosome-based immunoactive compositions are provided. The immunogenic compositions, which include Proteosomes and liposaccharides, may...
US20090220541 EMULSIONS WITH FREE AQUEOUS-PHASE SURFACTANT FOR ADJUVANTING SPLIT INFLUENZA VACCINES  
A split influenza virus vaccine is adjuvanted with an oil-in-water emulsion that contains free surfactant in its aqueous phase. The free surfactant can continue to exert a “splitting effect” on...
US20090104226 Alphavirus Vectors for Respiratory Pathogen Vaccines  
Described herein are compositions and methods for stimulating an immune response to one or more proteins derived from one or more respiratory pathogens. In particular, the invention relates to...
US20110200635 COMBINED INFLUENZA VACCINES FOR SEASONAL AND PANDEMIC PROTECTION  
Current approaches to influenza vaccination focus either on seasonal strains or pandemic strains. Current seasonal vaccines typically include antigens from two influenza A strains (H1N1 and H3N2)...
US20080254065 Influenza Virus Vaccines  
The invention provides a vaccine for protecting a human patient against infection by a human influenza virus strain, wherein the vaccine comprises an antigen from an avian influenza virus strain...
US20090028903 Novel use  
The present invention relates to influenza vaccine formulations and vaccination regimes for immunising against influenza disease. In particular the invention relates to vaccine formulations...
US20080292658 Defective Influenza Virus Particles  
The invention relates to the field of influenza virus and the vaccination against flu. The invention provides a conditionally defective influenza virus particle having seven different influenza...
US20070253978 Copy choice recombination and uses thereof  
The instant invention provides methods for determining, predicting and characterizing the genetic variability of a range of organisms, including, e.g., viruses, microbes, cells and multicellular...
US20090123367 Soluble Glycosaminoglycanases and Methods of Preparing and Using Soluble Glycosaminoglycanases  
The invention relates to the discovery of novel soluble neutral active Hyaluronidase Glycoproteins (sHASEGPs), methods of manufacture, and their use to facilitate administration of other molecules...
US20090047353 CHANGING TH1/TH2 BALANCE IN SPLIT INFLUENZA VACCINES WITH ADJUVANTS  
The invention seeks to avoid components in split vaccines that could cause an excessive Th2 response. Thus the invention provides an immunogenic composition comprising a split influenza virus...
US20090104228 Influenza Virus Vaccine  
The invention relates to influenza virus vaccines, and in particular to a reassortant influenza virus which has at least its hemagglutinin gene derived from a non-pathogenic or low pathogenic...
US20110142912 NON-SPECIFIC IMMUNOSTIMULATING AGENTS  
The present invention relates to the use of a lipid vesicle for the preparation of a medicament. The invention further relates to a method of treating and/or preventing a disease or disorder...
US20090304735 Immunogenic Compositions  
The present invention relates to an immunogenic composition for raising an immune response to an antigen, the composition comprising the antigen and a targeting moiety specific for lymph-resident...
US20100068223 Storage of Influenza Vaccines Without Refrigeration  
Antigens from individual influenza virus strains are not refrigerated before being combined to make multivalent influenza virus vaccines. Moreover, influenza vaccines are not refrigerated between...
US20090110698 METHOD OF DETERMINING VACCINE COMPLIANCE  
A protein (xylanase) has been identified that produces a strong immune response in pigs when added to a vaccine. The protein is added to vaccines at a particular concentration. The protein is...
US20090004222 Influenza Vaccination  
Influenza viruses have traditionally been administered by intramuscular injection. The invention is based on the idea of using alternative routes of delivery for influenza vaccines, more...
US20160228825 TREATED FILTER  
The present application provides methods for filtering a fluid through a filter, wherein the fluid comprises a biological product of interest, such as proteinaceous matter. The biological product...
US20150153330 sAPP-alpha as a Biomarker for Prediction of Inflammatory and Autoimmune-Related Disorders  
The subject invention pertains to the use of amyloid precursor protein-alpha (sAPP-α) as a biomarker for prediction of a subject's risk of developing inflammatory and/or autoimmune-related...
US20100086485 INFLUENZA VACCINE  
The present invention relates to a live-attenuated bacterial cell comprising a heterologous nucleotide sequence encoding at least one influenza virus antigen in operative linkage to an expression...
US20090098143 VACCINE PRODUCTION FOR PATHOGENIC BIRD VIRAL DISEASES  
The present invention is an improved method for the production of vaccines to transmittable viral pathogens where the virus is pathogenic to the chicken embryos. Bird embryos are selected for...
US20100233204 Immunogenic Compositions and Methods for Treating and Preventing Animal Infections  
The present disclosure relates to multivalent immunogen compositions for treating or preventing diseases or disorders in canines caused by or associated with one or more of canine distemper virus,...
US20080299150 METHOD AND SYSTEM FOR PROCESSING IMMUNO-COMPETENT CELLS IN VIEW OF AN ANTIVIRAL THERAPY, AND RELATED THERAPEUTIC PROCESS  
A method for processing immuno-competent cells in view of an antiviral therapy on a human or animal subject, includes: a step for collecting immuno-competent cells on the human or animal subject,...
US20090130144 Direct vaccination of the bone marrow  
The present invention provides methods for eliciting an effective immune response against a weakly immunogenic disease or for priming T cells to become memory T cells against a weakly immunogenic...

Matches 1 - 50 out of 52 1 2 >